Purchase Order 75N93020P00954
Award Date 7/23/20
Potential Completion Date 7/22/21
Potential Value $342K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Cambodia
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $341,700.00 firm fixed price purchase order to Illumina, Inc. for the NEXTSEQ 2000 SEQUENCING SYSTEM in support of COVID-19 response efforts. The award was made on August 17, 2020 with a completion date of December 31, 2020. Illumina is a manufacturer and provider of sequencing and array-based genomic analysis solutions, and has a history of providing...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions, to provide a NEXTSEQ 2000 SEQUENCING SYSTEM in support of COVID-19 research. The $338,350.00 contract has a completion date of September 25, 2020 and was awarded on June 22, 2020 with no set-aside designation. Illumina has previously provided sequencing...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $193,260.38 firm fixed price delivery order to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The award is for the provision of Illumina NextSeq, iSeq, and MiSeq sequencing kits to support COVID-19 research. Illumina has previously received prime federal contracts and subcontracts from agencies such as the National Institutes of...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $289,275 firm-fixed price purchase order to Illumina, Inc. of San Diego, California. The contract is for one NEXTSEQ 2000 SEQUENCING SYSTEM to support ongoing COVID-19 and infectious disease research. Delivery is required by January 31, 2023 in Bethesda, Maryland per the original solicitation seeking offers for the Illumina NextSeq-2000 sequencing system and...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a delivery order contract to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The contract is for the purchase of NextSeq 1000/2000 and MiSeq reagent kits, valued at $109,656.60. The order supports the agency's Coronavirus COVID-19 response efforts. The contract is awarded on a firm fixed-price basis with no set-aside...
- The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $340,025 firm fixed price purchase order to Illumina, Inc. to deliver one NextSEQ2000 genome sequencer to the Laboratory of Parasitic Diseases. The sequencer will support the laboratory's SARS-CoV-2 and other research efforts. As the prime contractor, Illumina will furnish the requested high-throughput sequencer from its San Diego, California location by the end date of October 25, 2021 to meet...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm fixed price delivery order to Illumina, Inc., a for-profit manufacturer of genomic sequencing systems and reagents, for the provision of Illumina's NovaSeq reagent kits. The $107,866.08 contract supports COVID-19 research and has a completion date of May 7, 2024. Illumina has previously held prime federal contracts with agencies such as the...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc. to provide an Illumina NextSeq 550 sequencing system. The potential value of the contract is $273,655.08. There was no set-aside designation for this award. Illumina, a for-profit manufacturer of genetic and genomic analysis instruments and reagents, has provided a range of sequencing systems and related...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc. for a NextSeq 2000 Sequencing System or equal, valued at $239,700.00. The requirement was issued through a commercial items solicitation using Simplified Acquisition Procedures, with no set-aside designation. The sequencing system is intended to support the increased workload at the Center for Human Immunology,...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price delivery order to Illumina, Inc., a for-profit manufacturer of genomic sequencing systems and reagents, for $105,341.32. The order includes various sequencing products such as the NovaSeq 6000 S2 Reagent Kit, NovaSeq XP 2-Lane Kit, MiSeq Reagent Kit V2, and Nextera XT DNA Library Preparation Kit to support life science research, applied...